Evogene (EVGN) Reports Q1 Loss of $0.15

May 28, 2019 7:03 AM

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.15), versus ($0.21) reported last year. Revenue for the quarter came in at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found